The US patent system is about to undergo a major change under the proposed Patent Reform Act of 2007. The implications could be considerable for the pharmaceutical and biotech industry. Some of the proposed changes should be welcomed. However, other parts of the proposed Act are of concern and could potentially impact the operational environment for the discovery of life-saving drugs.